Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mifepristone (RU-486) in androgen independent prostate cancer

Mifepristone (RU-486) in androgen independent prostate cancer. J Clin Oncol. 2006; 24(18S):14508.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.